ArticleCancer communications (London, England)2020

BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphoma.

Xiao-Peng Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.